Item 16. Form 10-K Summary

Not applicable.

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


AXON ENTERPRISE, INC.

Date: February 28, 2023
	By:	/s/ PATRICK W. SMITH
		Chief Executive Officer, Director
		(Principal Executive Officer)

Date: February 28, 2023	By:	/s/ BRITTANY BAGLEY
		Chief Financial Officer and Chief Business Officer
		(Principal Financial and Accounting Officer)

POWER OF ATTORNEY

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Patrick W. Smith his or her true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, for him or her in any and all capacities, to sign any amendments to this Annual Report on Form 10-K, and to file the same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, hereby ratifying and confirming all that each of said attorneys-in-fact, or his substitute or substitutes, may do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

Signature	Title	Date

	Chief Executive Officer, Director
/s/ PATRICK W. SMITH	(Principal Executive Officer)	February 28, 2023
Patrick W. Smith

	Chief Financial Officer and Chief Business Officer
/s/ BRITTANY BAGLEY	(Principal Financial and Accounting Officer)	February 28, 2023
Brittany Bagley

/s/ ADRIANE M. BROWN	Director	February 28, 2023
Adriane M. Brown

/s/ JULIE A. CULLIVAN	Director	February 28, 2023
Julie A. Cullivan

/s/ MICHAEL GARNREITER	Director	February 28, 2023
Michael Garnreiter

/s/ CAITLIN E. KALINOWSKI	Director	February 28, 2023
Caitlin E. Kalinowski

/s/ MARK W. KROLL	Director	February 28, 2023
Mark W. Kroll

/s/ MATTHEW R. MCBRADY	Director	February 28, 2023
Matthew R. McBrady

/s/ HADI PARTOVI	Director	February 28, 2023
Hadi Partovi

Previous: Item 15. Exhibits, Financial Statement Schedules